
|Slideshows|May 23, 2018
Antibody Testing in Patients With Neurological and Psychiatric Symptoms
Author(s)Veronica Hackethal, MD
New research may help doctors determine when (and when not) to test for antiglutamate decarboxylase antibodies in patients with neurological disorders and psychiatric symptoms.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
uniQure Submits BLA for Gene Therapy in HD, AAN, AHS Issue Updated Guideline on Migraine Prevention, CTE Prevalence, Brain Donation Findings in Former NFL Players
2
Phase 4 Study Highlights Valbenazine's Positive Impact on Patient-Reported Quality of Life, Daily Functioning in Tardive Dyskinesia
3
FDA Action Update, August 2026: Approvals, Clearances, and Designations
4
FDA Approves Zilganersen, First Treatment for Alexander Disease
5














